BIOWKS Stock Overview
A biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bio-Works Technologies AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.89 |
| 52 Week High | SEK 8.40 |
| 52 Week Low | SEK 0.76 |
| Beta | 1.18 |
| 11 Month Change | 8.55% |
| 3 Month Change | -33.58% |
| 1 Year Change | -83.52% |
| 33 Year Change | -96.59% |
| 5 Year Change | -89.65% |
| Change since IPO | -92.88% |
Recent News & Updates
Recent updates
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth
Dec 25
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth
Aug 30We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth
Feb 21We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth
Oct 25We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth
May 10Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business
Sep 27Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?
May 11Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling
Mar 20How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?
Dec 05
Shareholder Returns
| BIOWKS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -3.1% | 0.8% | 0.7% |
| 1Y | -83.5% | -4.3% | 12.3% |
Return vs Industry: BIOWKS underperformed the Swedish Medical Equipment industry which returned -6% over the past year.
Return vs Market: BIOWKS underperformed the Swedish Market which returned 11.8% over the past year.
Price Volatility
| BIOWKS volatility | |
|---|---|
| BIOWKS Average Weekly Movement | 9.7% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: BIOWKS's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: BIOWKS's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 35 | Lone Carlbom | www.bio-works.com |
Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.
Bio-Works Technologies AB (publ) Fundamentals Summary
| BIOWKS fundamental statistics | |
|---|---|
| Market cap | SEK 69.38m |
| Earnings (TTM) | -SEK 37.52m |
| Revenue (TTM) | SEK 37.88m |
1.8x
P/S Ratio-1.8x
P/E RatioIs BIOWKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOWKS income statement (TTM) | |
|---|---|
| Revenue | SEK 37.88m |
| Cost of Revenue | SEK 10.16m |
| Gross Profit | SEK 27.72m |
| Other Expenses | SEK 65.24m |
| Earnings | -SEK 37.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 21, 2025
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 73.18% |
| Net Profit Margin | -99.05% |
| Debt/Equity Ratio | 0% |
How did BIOWKS perform over the long term?
See historical performance and comparison